Alternative splicing of Bim and Erk-mediated Bim(EL) phosphorylation are dispensable for hematopoietic homeostasis in vivo
- Author(s)
- Clybouw, C; Merino, D; Nebl, T; Masson, F; Robati, M; O'Reilly, L; Hubner, A; Davis, RJ; Strasser, A; Bouillet, P;
- Details
- Publication Year 2012-06,Volume 19,Issue #6,Page 1060-1068
- Journal Title
- CELL DEATH AND DIFFERENTIATION
- Publication Type
- Journal Article
- Abstract
- The pro-apoptotic BH3-only protein Bim has a major role in hematopoietic homeostasis, particularly in the lymphocyte compartment, where it strongly affects immune function. The three major Bim isoforms (Bim(EL), Bim(L) and Bim(S)) are generated by alternative splicing. Bim(EL), the most abundant isoform, contains a unique sequence that has been reported to be the target of phosphorylation by several MAP kinases. In particular, Erk1/2 has been shown to interact with Bim(EL) through the DEF2 domain of Bim(EL) and specifically phosphorylate this isoform, thereby targeting it for ubiquitination and proteasomal degradation. To examine the physiological importance of this mechanism of regulation and of the alternative splicing of Bim, we have generated several Bim knock-in mouse strains and analyzed their hematopoietic system. Although mutation in the DEF2 domain reduces Bim(EL) degradation in some circumstances, this mutation did not significantly increase Bim's pro-apoptotic activity in vivo nor impact on the homeostasis of the hematopoietic system. We also show that Bim(EL) and Bim(L) are interchangeable, and that Bim(S) is dispensable for the function of Bim. Hence, we conclude that physiological regulation of Bim relies on mechanisms independent of its alternative splicing or the Erk-dependent phosphorylation of Bim(EL). Cell Death and Differentiation (2012) 19, 1060-1068; doi:10.1038/cdd.2011.198; published online 13 January 2012
- Publisher
- NATURE PUBLISHING GROUP
- Keywords
- Bcl-2 family ; Bim ; ERK-mediated phosphorylation ; isoforms
- Research Division(s)
- Molecular Genetics Of Cancer
- Link To PubMed Central Version
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354058/
- Publisher's Version
- https://doi.org/10.1038/cdd.2011.198
- Terms of Use/Rights Notice
- Copyright © 2012 Macmillan Publishers Limited
Creation Date: 2012-06-01 12:00:00